MedTrace Logo

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

NCT00691665 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2010-03-30

Study results available
· View outcomes & findings →

Summary

Comparison of two nasal sprays for the treatment of seasonal allergic rhinitis

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

Olopatadine HCL Nasal Spray, 0.6%

Olopatadine HCL Nasal Spray, 0.6% 2 sprays per nostril twice daily

DRUG

Fluticasone Propionate Nasal Spray, 50 mcg

Fluticasone Propionate Nasal Spray, 50 mcg 2 sprays per nostril once daily

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00691665 on ClinicalTrials.gov